Basics Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure. IPO Date: March 1, 2007 Sector: Healthcare Industry: Biotech Market Cap: $308.13M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.94% Avg Daily Range (30 D): $0.25 | 3.40% Avg Daily Range (90 D): $0.48 | 5.10% Institutional Daily Volume Avg Daily Volume: .65M Avg Daily Volume (30 D): 1.52M Avg Daily Volume (90 D): 2.37M Trade Size Avg Trade Size (Sh.): 184 Avg Trade Size (Sh.) (30 D): 135 Avg Trade Size (Sh.) (90 D): 125 Institutional Trades Total Inst.Trades: 319 Avg Inst. Trade: $1.29M Avg Inst. Trade (30 D): $.83M Avg Inst. Trade (90 D): $1.03M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.46M Avg Closing Trade (30 D): $.84M Avg Closing Trade (90 D): $1.12M Avg Closing Volume: 126.72K     News Sep 7, 2025 @ 2:50 PM CAPRICOR ALERT: Bragar Eagel & Squire, P.C. Announ... Source: Bragar Eagel & Squire, P.C. Sep 7, 2025 @ 12:55 PM Faruqi & Faruqi Reminds Capricor Investors of the ... Source: Faruqi & Faruqi, Llp Sep 5, 2025 @ 11:30 PM CAPR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEY... Source: Rosen Law Firm Sep 5, 2025 @ 9:44 PM Capricor Therapeutics, Inc. Investors: Please cont... Source: Portnoy Law Firm Sep 5, 2025 @ 8:57 PM Capricor Therapeutics, Inc. Class Action: Levi & K... Source: Levi & Korsinsky, Llp Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.57 $-.53 $-.11 Diluted EPS $-.57 $-.53 $-.11 Revenue $ M $ M $ 11.13M Gross Profit $ $ $ Net Income / Loss $ -25.91M $ -24.39M $ -7.12M Operating Income / Loss $ -27.72M $ -24.98M $ -7.7M Cost of Revenue $ $ $ Net Cash Flow $ -5.55M $ 17.51M $ -57.09M PE Ratio     Splits Jun 05, 2019:   1:10 Nov 21, 2013:   1:50 Feb 09, 2007:   1:10 Apr 05, 2005:   1:20